Suppr超能文献

肿瘤坏死因子受体 2 使肿瘤坏死因子成为肿瘤的朋友。

TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors.

机构信息

Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Front Immunol. 2018 May 28;9:1170. doi: 10.3389/fimmu.2018.01170. eCollection 2018.

Abstract

Tumor necrosis factor (TNF) is widely accepted as a tumor-suppressive cytokine its ubiquitous receptor TNF receptor 1 (TNFR1). The other receptor, TNFR2, is not only expressed on some tumor cells but also on suppressive immune cells, including regulatory T cells and myeloid-derived suppressor cells. In contrast to TNFR1, TNFR2 diverts the tumor-inhibiting TNF into a tumor-advocating factor. TNFR2 directly promotes the proliferation of some kinds of tumor cells. Also activating immunosuppressive cells, it supports immune escape and tumor development. Hence, TNFR2 may represent a potential target of cancer therapy. Here, we focus on expression and role of TNFR2 in the tumor microenvironment. We summarize the recent progress in understanding how TNFR2-dependent mechanisms promote carcinogenesis and tumor growth and discuss the potential value of TNFR2 in cancer treatment.

摘要

肿瘤坏死因子 (TNF) 被广泛认为是一种肿瘤抑制细胞因子,其广泛表达的受体为 TNF 受体 1(TNFR1)。另一个受体 TNFR2 不仅在一些肿瘤细胞上表达,也在抑制性免疫细胞上表达,包括调节性 T 细胞和髓源性抑制细胞。与 TNFR1 不同,TNFR2 将具有抑瘤作用的 TNF 转化为促进肿瘤生长的因子。TNFR2 直接促进某些类型的肿瘤细胞增殖。同时,它还激活免疫抑制细胞,支持免疫逃逸和肿瘤发展。因此,TNFR2 可能成为癌症治疗的一个潜在靶点。本文主要关注 TNFR2 在肿瘤微环境中的表达和作用。我们总结了近年来对 TNFR2 依赖性机制促进致癌作用和肿瘤生长的理解方面的进展,并讨论了 TNFR2 在癌症治疗中的潜在价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2b0/5985372/de3b33e5284d/fimmu-09-01170-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验